[Sulfobromophthalein clearance and survival of cirrhotics after an elective porto-systemic shunt].
Preoperative clearance of a single dose of BSP was assessed in 72 candidates for porto-systemic shunt in cirrhosis of the liver. Comparison between those who had died (24) and those who had survived (48) several years later showed statistically significant differences with regard to equivalent liver volume, first uncorrected exponential (Ki), absolute clearance, and 45' retention. A certain degree of differentiation could be made out among the survivors, whereas those who had died could not be distinguished from the series as a whole, nor could correlations be established with the length of survival. No practical advantage was displayed by the more complex, computer-processed parameters as opposed to those that were more immediately available.
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000601:surgery*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011167:Portacaval Shunt, Surgical; D011169:Portal Vein / Q000601:surgery; D011183:Postoperative Complications; D011300:Preoperative Care; D011379:Prognosis; D012082:Renal Veins / Q000601:surgery; D013162:Splenic Vein / Q000601:surgery
Clearance della bromosulfonftaleina (B.S.F.) e sopravvivenza dei cirrotici dopo uno shunt porto-sistemico di elezione.